Alkem Laboratories launched the "Stop Sneeze to Wheeze" awareness initiative on World Allergy Week to raise awareness about the coexistence of Allergic Rhinitis and Asthma – One Airway, One Disease. These two respiratory conditions often occur together, impacting millions of people worldwide. The initiative aims to emphasize the importance of early diagnosis, effective management, and improved quality of life for patients living with these conditions.

Allergic Rhinitis, commonly referred to as hay fever, is an inflammatory condition affecting the nasal passages, triggered by allergens like pollen, dust mites, pet dander, and mold spores. If left untreated, it can progress to asthma, a chronic respiratory condition characterized by airway inflammation and heightened sensitivity to triggers.

The coexistence of Allergic Rhinitis and Asthma results in unique challenges for individuals, as these conditions interact and worsen each other's symptoms. Allergic Rhinitis can exacerbate asthma symptoms, while uncontrolled asthma can further intensify Allergic Rhinitis symptoms, leading to a distressing cycle of respiratory difficulties that significantly impact a person's quality of life.

Sudipta Roy, President, Head - Acute business, Alkem Laboratories said, “The incidence of Asthma and Allergic Rhinitis is on the rise within the general population, with a significant number of newly diagnosed patients experiencing both upper and lower airway symptoms. Recent estimates suggest that approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis.”

“To address this pressing health concern, Alkem Laboratories in collaboration with healthcare providers, has designed a comprehensive awareness campaign as part of the "Stop Sneeze to Wheeze" initiative through a series of awareness drives, camps, and clinics, the campaign aims to educate the public and patients,” Roy added.

During this World Allergy Week, let us unite in raising awareness about the concept of "One Airway, One Disease" and empowering individuals who have both Allergic Rhinitis and Asthma to take charge of their health. Through collaborative efforts, we can promote early diagnosis and effective management of these coexisting conditions.